Havard University grants license to Beam Therapeutics to develop new base editing technology – News-Medical.net
News-Medical.net |
Havard University grants license to Beam Therapeutics to develop new base editing technology
News-Medical.net Genome editing technologies using the CRISPR platform in combination with enzymes like Cas9 and Cpf1 have shown great promise for adjusting genes through insertions or deletions of multiple nucleotides, but have had more difficulty correcting single … |
